On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Teva had listed nine patents in the Orange Book for its ProAir® HFA albuterol inhaler. Five of the patents were directed to a dose counter used for the delivery device or the canister used to ...

The leak rates for the Proventil HFA test and control MDIs were similar at the start of testing and at one month, but test MDIs exhibited increased propellant loss at three and six months.

Amneal beats Teva’s challenge of ruling on some ProAir patents Decision could impact other ‘junk device listings,’ FTC says Five patents related to Teva Pharmaceutical Industries Ltd.’s ProAir HFA ...